These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36614035)

  • 21. The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development.
    Sumter TF; Xian L; Huso T; Koo M; Chang YT; Almasri TN; Chia L; Inglis C; Reid D; Resar LM
    Curr Mol Med; 2016; 16(4):353-93. PubMed ID: 26980699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of adriamycin with a promoter region of hmga1 and its inhibitory effect on HMGA1 expression in A431 human squamous carcinoma cell line.
    Akhter MZ; Sharma A; Rajeswari MR
    Mol Biosyst; 2011 Apr; 7(4):1336-46. PubMed ID: 21336378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The High Mobility Group A1 (HMGA1) gene is highly overexpressed in human uterine serous carcinomas and carcinosarcomas and drives Matrix Metalloproteinase-2 (MMP-2) in a subset of tumors.
    Hillion J; Roy S; Heydarian M; Cope L; Xian L; Koo M; Luo LZ; Kellyn K; Ronnett BM; Huso T; Armstrong D; Reddy K; Huso DL; Resar LMS
    Gynecol Oncol; 2016 Jun; 141(3):580-587. PubMed ID: 27001612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High Mobility Group A1 (HMGA1): Structure, Biological Function, and Therapeutic Potential.
    Wang L; Zhang J; Xia M; Liu C; Zu X; Zhong J
    Int J Biol Sci; 2022; 18(11):4414-4431. PubMed ID: 35864955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HMGA1 exacerbates tumor growth through regulating the cell cycle and accelerates migration/invasion via targeting miR-221/222 in cervical cancer.
    Fu F; Wang T; Wu Z; Feng Y; Wang W; Zhou S; Ma X; Wang S
    Cell Death Dis; 2018 May; 9(6):594. PubMed ID: 29789601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knockdown of HMGA1 inhibits human breast cancer cell growth and metastasis in immunodeficient mice.
    Di Cello F; Shin J; Harbom K; Brayton C
    Biochem Biophys Res Commun; 2013 Apr; 434(1):70-4. PubMed ID: 23545254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The High Mobility Group A1 (HMGA1) Chromatin Architectural Factor Modulates Nuclear Stiffness in Breast Cancer Cells.
    Senigagliesi B; Penzo C; Severino LU; Maraspini R; Petrosino S; Morales-Navarrete H; Pobega E; Ambrosetti E; Parisse P; Pegoraro S; Manfioletti G; Casalis L; Sgarra R
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31167352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hmga1 is differentially expressed and mediates silencing of the CD4/CD8 loci in T cell lineages and leukemic cells.
    Xi Y; Watanabe S; Hino Y; Sakamoto C; Nakatsu Y; Okada S; Nakao M
    Cancer Sci; 2012 Mar; 103(3):439-47. PubMed ID: 22106824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HMGA1 promotes metastatic processes in basal-like breast cancer regulating EMT and stemness.
    Pegoraro S; Ros G; Piazza S; Sommaggio R; Ciani Y; Rosato A; Sgarra R; Del Sal G; Manfioletti G
    Oncotarget; 2013 Aug; 4(8):1293-308. PubMed ID: 23945276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HMGA1 silencing restores normal stem cell characteristics in colon cancer stem cells by increasing p53 levels.
    Puca F; Colamaio M; Federico A; Gemei M; Tosti N; Bastos AU; Del Vecchio L; Pece S; Battista S; Fusco A
    Oncotarget; 2014 May; 5(10):3234-45. PubMed ID: 24833610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HMGA1 induces FGF19 to drive pancreatic carcinogenesis and stroma formation.
    Chia L; Wang B; Kim JH; Luo LZ; Shuai S; Herrera I; Chen SY; Li L; Xian L; Huso T; Heydarian M; Reddy K; Sung WJ; Ishiyama S; Guo G; Jaffee E; Zheng L; Cope LM; Gabrielson K; Wood L; Resar L
    J Clin Invest; 2023 Mar; 133(6):. PubMed ID: 36919699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRMP1 Inhibits Proliferation of Medulloblastoma and Is Regulated by HMGA1.
    Li KK; Qi Y; Xia T; Yao Y; Zhou L; Lau KM; Ng HK
    PLoS One; 2015; 10(5):e0127910. PubMed ID: 26009886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of miR‑26a exhibits a negative correlation with HMGA1 and regulates cancer progression by targeting HMGA1 in lung adenocarcinoma cells.
    Sekimoto N; Suzuki A; Suzuki Y; Sugano S
    Mol Med Rep; 2017 Feb; 15(2):534-542. PubMed ID: 28000891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HMGA1 regulates the Plasminogen activation system in the secretome of breast cancer cells.
    Resmini G; Rizzo S; Franchin C; Zanin R; Penzo C; Pegoraro S; Ciani Y; Piazza S; Arrigoni G; Sgarra R; Manfioletti G
    Sci Rep; 2017 Sep; 7(1):11768. PubMed ID: 28924209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human KIT ligand promoter is positively regulated by HMGA1 in breast and ovarian cancer cells.
    Treff NR; Dement GA; Adair JE; Britt RL; Nie R; Shima JE; Taylor WE; Reeves R
    Oncogene; 2004 Nov; 23(52):8557-62. PubMed ID: 15378028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HMGA1 promoting gastric cancer oncogenic and glycolytic phenotypes by regulating c-myc expression.
    Cao XP; Cao Y; Zhao H; Yin J; Hou P
    Biochem Biophys Res Commun; 2019 Aug; 516(2):457-465. PubMed ID: 31229266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HMGA1 protein is a novel target of the ATM kinase.
    Pentimalli F; Palmieri D; Pacelli R; Garbi C; Cesari R; Martin E; Pierantoni GM; Chieffi P; Croce CM; Costanzo V; Fedele M; Fusco A
    Eur J Cancer; 2008 Nov; 44(17):2668-79. PubMed ID: 18783938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Wnt/β-catenin/T-cell factor 4 pathway up-regulates high-mobility group A1 expression in colon cancer.
    Bush BM; Brock AT; Deng JA; Nelson RA; Sumter TF
    Cell Biochem Funct; 2013 Apr; 31(3):228-36. PubMed ID: 22961697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of 6-Phosphogluconate Dehydrogenase Reverses Epirubicin Resistance Through Metabolic Reprograming in Triple-Negative Breast Cancer Cells.
    Xu J; Ren G; Cheng Q
    Technol Cancer Res Treat; 2023; 22():15330338231190737. PubMed ID: 37559469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of transcription factor EB dysregulates the G1/S transition and DNA replication in mammary epithelial cells.
    Slade L; Biswas D; Kienesberger PC; Pulinilkunnil T
    J Biol Chem; 2022 Dec; 298(12):102692. PubMed ID: 36372230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.